Evidence map›Paper›PMID 41540905›Full record

ArticleJournal of cellular biochemistry2026

HEPES in Cell Culture Alters the Multi-Omics Profile Exhibited by Gaucher Disease Fibroblasts.

Eleonore M Corazolla, Bauke V Schomakers, Maria M Trętowicz, Jill Hermans, Michel van Weeghel, Frédéric M Vaz, Mia L Pras-Raves, Karen Ghauharali-van der Vlugt, Femke S Beers-Stet, Susanna M I Goorden and 5 more

Abstract read
In one paragraph

Article in Journal of cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Eleonore M CorazollaDepartment of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.ORCID https://orcid.org/0000-0003-2787-2549
Bauke V SchomakersLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.ORCID https://orcid.org/0000-0002-0242-9113
Maria M TrętowiczLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Jill HermansLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Michel van WeeghelLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.ORCID https://orcid.org/0000-0002-4916-2866
Frédéric M VazLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Mia L Pras-RavesCore Facility Metabolomics, Amsterdam UMC, Amsterdam, North-Holland, Netherlands.
Karen Ghauharali-van der VlugtLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Femke S Beers-StetLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Susanna M I GoordenLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Judith Jansen-MeijerLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Georges E JanssensLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
Carla E M HollakDepartment of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.ORCID https://orcid.org/0000-0003-0464-1078
Riekelt H HoutkooperLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, North-Holland, Netherlands.
André B P van KuilenburgAmsterdam Gastroenterology Endocrinology and Metabolism Institute, Amsterdam, North-Holland, Netherlands.ORCID https://orcid.org/0000-0002-7989-4910

Funding

Amsterdam University Medical Center
6 · The paper itself

Abstract

Lysosomal function can be affected by components in cell culture. This in turn may influence cellular metabolism and, consequently, research and diagnostics outcomes. One such component is the commonly used pH buffer 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). HEPES specifically impacts the trafficking of the lysosomal enzyme glucocerebrosidase, which is deficient in Gaucher disease (GD). Understanding how HEPES affects cellular models of GD is essential, since glucocerebrosidase is central to diagnostic testing and the investigation of GD pathophysiology. Therefore, we examined the broader effects of HEPES on cultured fibroblasts from individuals with GD and healthy controls. We cultured dermal fibroblasts of eight adults with GD and seven healthy age- and sex-matched controls. The cells were cultured in two culture media, Ham's F10 and DMEM, both with and without HEPES. We assessed glucocerebrosidase enzyme activity and sphingolipid concentrations using a quantitative UPLC-MS/MS method. Additionally, we conducted multi-omics analyses, consisting of lipidomics, metabolomics and proteomics, to explore the broader impact of HEPES in cell culture on fibroblasts. Glucocerebrosidase activity in cell lysates increased after HEPES exposure in both GD and control fibroblasts, to an extent that may influence diagnostic outcomes. In GD fibroblasts, substrate accumulation was absent and not altered by HEPES exposure. GD fibroblasts exhibited a multi-omics profile largely overlapping with healthy controls and lacking the typical pathological features associated with GD in other cell types, such as mitochondrial dysfunction, dysregulated autophagy, disruption of intracellular calcium homeostasis, ER stress and chronic oxidative stress. In addition, the multi-omics profile was altered by HEPES, however in a non-specific manner. In conclusion, HEPES influences fibroblasts in culture, both from healthy controls and from patients with GD. Furthermore, GD fibroblasts lack a specific disease-related profile. This renders cultured fibroblasts unsuitable for studying pathophysiological processes in GD. Culturing GD fibroblasts with HEPES may compromise the reliability of diagnostics.

Indexed as

FibroblastsGaucher DiseaseAdultCase-Control StudiesCells, CulturedFemaleGlucosylceramidaseHumansMaleMetabolomicsMiddle AgedMultiomicsProteomicsGlucosylceramidasecell culture techniquesGaucher diseaseHEPESmulti‐omics

Identifiers

PMID41540905
PMCPMC12809196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.